A focus on off-label medicines, and why more regulation is needed



A new pan-European study of 150 patient groups (undertaken by PatientView) in the area of off-label prescribing*. ‘Off-label prescribing’ occurs when a doctor prescribes a medicine—the safety and efficacy of which has not been established for a specific use.

To see the press release and read the report go to: http://bit.ly/zoXO3N